Skip to main content
. Author manuscript; available in PMC: 2019 Dec 28.
Published in final edited form as: Cancer Lett. 2018 Sep 19;439:56–65. doi: 10.1016/j.canlet.2018.09.024

Table 2.

: Dose Reduction Index (DRI) of volasertib (BI6727) and BKM120 combination in ATC cell lines.

DRI EC75 DRI EC90
BI6727 BKM120 BI6727 BKM120
T4888M 2.44 20.44 3.05 58.63
T3533 2.58 2.33 3.11 2.6
T1903 4.28 2.81 3.76 2.33
A22 2.27 2.73 3.51 3.75
A275 1.68 6.03 1.92 13.83
3531L 2.62 2.53 2.68 2.36
THJ16T 2.6 13.21 1.84 14.16
T238 4.05 2.15 6.04 2.24
OCUT2 1.93 3.05 0.76 1.35
SW1736 1.55 9.62 1.56 18.91
BHT101 2.01 4.51 1.9 4.66
8505C 1.01 1.98 1.08 2.9
C643 3.43 4.06 2.5 1.24
CAL62 0.92 15.32 0.94 31.53